May 22, 2017 — Consumers are being warned about the accuracy of heart rate apps after a study found huge variability ...
Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced the signing of a definitive license agreement for the continued Phase III development and worldwide commercialization of flurpiridaz F-18. Flurpiridaz F-18 is an investigational positron emission tomography (PET) myocardial perfusion imaging (MPI) agent that may improve the diagnosis of coronary artery disease (CAD), the most common form of heart disease. The definitive agreement follows the signing of a term sheet previously announced in late February 2017.
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports of ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 19, 2017 — TherOx Inc. announced that it completed enrollment in the IC-HOT (Evaluation of Intracoronary Hyperoxemic ...
Nearly one-quarter of patients with a mechanical heart valve say it disturbs their sleep, according to research presented at EuroHeartCare 2017, May 18-20 in Jonkoping, Sweden.
Hugh Calkins, M.D., FACC, FAHA, FHRS, director of cardiac arrhythmia services and professor of medicine at Johns Hopkins ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 12, 2017 – Results from the U.S. post-market approval study evaluating “real-world” patients implanted with the ...
This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidental ...
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigational ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 17, 2017 — A new intravenous occlusion balloon designed to seal any accidental tears in the superior vena cava (SVC) ...
May 17, 2017 — Partners HealthCare and GE Healthcare announced a 10-year collaboration to rapidly develop, validate and ...
Contego Medical LLC announced recently that it has received CE Marking of its Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection (IEP). The company intends to launch the Vanguard IEP System in Europe to endovascular specialists performing lower limb angioplasty procedures.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
An analysis of non ST-elevation myocardial infarction (NSTEMI) patients who undergo coronary revascularization within 24 hours of hospitalization showed an increased reduction in mortality, marking the first time this difference has been demonstrated. Results from “Outcomes of Early vs. Late Revascularization in Low and High-Risk Patients Hospitalized with Non-ST-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Surveillance Study” were presented as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions, May 10-13 in New Orleans.
May 16, 2017 - The preliminary results for the Medtronic Micra Transcatheter Pacing System (TPS) Post-Approval Registry ...
May 16, 2017 - The study using small, subcutaneous implantable cardiac monitors for long-term, 24-hour a day monitoring ...